{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:02:52Z","timestamp":1787695372341,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11906-025-01324-9","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:47:22Z","timestamp":1736923642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guidance for Prescribing Oral Antihypertensive Medications in the Emergency Department"],"prefix":"10.1007","volume":"27","author":[{"given":"Pia-Allison","family":"Roa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Akcasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip D.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Twiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"33","key":"1324_CR1","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J"},{"issue":"9349","key":"1324_CR2","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/s0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, et al. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903\u201313. https:\/\/doi.org\/10.1016\/s0140-6736(02)11911-8.","journal-title":"Lancet"},{"issue":"4","key":"1324_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ehjcvp\/pvx019","volume":"3","author":"GYH Lip","year":"2017","unstructured":"Lip GYH, Coca A, Kahan T, et al. Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana De Estimulaci\u00f3n Card\u00edaca Y Electrofisiolog\u00eda (SOLEACE). Eur Heart J Cardiovasc Pharmacother. 2017;3(4):235\u201350. https:\/\/doi.org\/10.1093\/ehjcvp\/pvx019.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"10","key":"1324_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","volume":"74","author":"RF Gottesman","year":"2017","unstructured":"Gottesman RF, Albert MS, Alonso A, et al. Associations between midlife vascular risk factors and 25-Year Incident Dementia in the atherosclerosis risk in communities (ARIC) Cohort. JAMA Neurol. 2017;74(10):1246\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1658.","journal-title":"JAMA Neurol"},{"issue":"23","key":"1324_CR5","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1016\/j.jacc.2019.03.507","volume":"73","author":"G Bakris","year":"2019","unstructured":"Bakris G, Ali W, Parati G. ACC\/AHA versus ESC\/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019;73(23):3018\u201326. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.507.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1324_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","volume":"5","author":"B-JH van den Born","year":"2019","unstructured":"van den Born B-JH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):37\u201346. https:\/\/doi.org\/10.1093\/ehjcvp\/pvy032.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"11","key":"1324_CR7","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.amjcard.2015.09.007","volume":"116","author":"CD McNaughton","year":"2015","unstructured":"McNaughton CD, Self WH, Zhu Y, et al. Incidence of Hypertension-Related Emergency Department Visits in the United States, 2006 to 2012. Am J Cardiol. 2015;116(11):1717\u201323. https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.007.","journal-title":"Am J Cardiol"},{"issue":"8","key":"1324_CR8","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.ajem.2019.10.004","volume":"38","author":"PM Mullins","year":"2020","unstructured":"Mullins PM, Levy PD, Mazer-Amirshahi M, Ghazi L, Li F, Chen X, et al. National trends in U.S. emergency department visits for chief complaint of hypertension (2006-15. Am J Emerg Med. 2020;38(8):1652\u20137. https:\/\/doi.org\/10.1016\/j.ajem.2019.10.004.","journal-title":"Am J Emerg Med"},{"key":"1324_CR9","doi-asserted-by":"publisher","unstructured":"Ghazi L, Li F, Chen X, et al. Blood pressure response to commonly administered antihypertensives for severe inpatient hypertension. PLoS ONE. 2022;17(4):e0265497.\nhttps:\/\/doi.org\/10.1371\/journal.pone.0265497.","DOI":"10.1371\/journal.pone.0265497"},{"issue":"2","key":"1324_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.amjmed.2019.10.004","volume":"13s3","author":"B Stanistreet","year":"2020","unstructured":"Stanistreet B, Nicholas JA, Bisognano JD. An evidence-based review of elevated blood pressure for the Inpatient. Am J Med. 2020;13s3(2):165\u20139. https:\/\/doi.org\/10.1016\/j.amjmed.2019.10.004.","journal-title":"Am J Med"},{"issue":"10","key":"1324_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/ajh\/hpaa068","volume":"33","author":"J Miller","year":"2020","unstructured":"Miller J, McNaughton C, Joyce K, et al. Hypertension management in emergency departments. Am J Hypertens. 2020;33(10):927\u201334. https:\/\/doi.org\/10.1093\/ajh\/hpaa068.","journal-title":"Am J Hypertens"},{"issue":"4","key":"1324_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11606-017-4277-6","volume":"33","author":"CL Campos","year":"2018","unstructured":"Campos CL, Herring CT, Ali AN, et al. Pharmacologic treatment of hypertensive urgency in the outpatient setting: a systematic review. J Gen Intern Med. 2018;33(4):539\u201350. https:\/\/doi.org\/10.1007\/s11606-017-4277-6.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"1324_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/acem.12660","volume":"22","author":"A Brody","year":"2015","unstructured":"Brody A, Rahman T, Reed B, et al. Safety and efficacy of antihypertensive prescription at emergency department discharge. Acad Emerg Med. 2015;22(5):632\u20135. https:\/\/doi.org\/10.1111\/acem.12660.","journal-title":"Acad Emerg Med"},{"issue":"19","key":"1324_CR14","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127\u2013248. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.006.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1324_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.annemergmed.2013.05.012","volume":"62","author":"SJ Wolf","year":"2013","unstructured":"Wolf SJ, Lo B, Shih RD, American College of Emergency Physicians Clinical Policies Committee, et al. Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med. 2013;62(1):59\u201368. https:\/\/doi.org\/10.1016\/j.annemergmed.2013.05.012.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"1324_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jash.2011.05.002","volume":"5","author":"BM Baumann","year":"2011","unstructured":"Baumann BM, Cline DM, Pimenta E. Treatment of hypertension in the emergency department. J Am Soc Hypertens. 2011;5(5):366\u201377. https:\/\/doi.org\/10.1016\/j.jash.2011.05.002.","journal-title":"J Am Soc Hypertens"},{"issue":"16","key":"1324_CR17","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","volume":"25","author":"J L\u00f3pez-Send\u00f3n","year":"2004","unstructured":"L\u00f3pez-Send\u00f3n J, Swedberg K, McMurray J, et al. Task Force on ACE-inhibitors of the European Society of Cardiology. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J. 2004;25(16):1454\u201370. https:\/\/doi.org\/10.1016\/j.ehj.2004.06.003.","journal-title":"Eur Heart J"},{"issue":"9","key":"1324_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3949\/ccjm.86a.18024","volume":"86","author":"T Momoniat","year":"2019","unstructured":"Momoniat T, Ilyas D, Bhandari S. ACE inhibitors and ARBs: Managing potassium and renal function. Cleve Clin J Med. 2019;86(9):601\u20137. https:\/\/doi.org\/10.3949\/ccjm.86a.18024.","journal-title":"Cleve Clin J Med"},{"issue":"18","key":"1324_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension: A review. JAMA. 2022;328(18):1849\u201361. https:\/\/doi.org\/10.1001\/jama.2022.19590.","journal-title":"JAMA."},{"issue":"10199","key":"1324_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(19)31629-0","volume":"394","author":"IJ Benjamin","year":"2019","unstructured":"Benjamin IJ, Kreutz R, Olsen MH, et al. Fixed-dose combination antihypertensive medications. Lancet. 2019;394(10199):637\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(19)31629-0.","journal-title":"Lancet"},{"issue":"1","key":"1324_CR21","doi-asserted-by":"publisher","first-page":"CD003654","DOI":"10.1002\/14651858.CD003654.pub6","volume":"1","author":"J Zhu","year":"2022","unstructured":"Zhu J, Chen N, Zhou M, et al. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev. 2022;1(1):CD003654. https:\/\/doi.org\/10.1002\/14651858.CD003654.pub6.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1324_CR22","doi-asserted-by":"publisher","first-page":"CD001841","DOI":"10.1002\/14651858.CD001841.pub3","volume":"4","author":"JM Wright","year":"2018","unstructured":"Wright JM, Musini VM, Gill R. First-line drugs for hypertension. Cochrane Database Syst Rev. 2018;4(4):CD001841. https:\/\/doi.org\/10.1002\/14651858.CD001841.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1324_CR23","doi-asserted-by":"publisher","first-page":"CD010316","DOI":"10.1002\/14651858.CD010316.pub3","volume":"2","author":"J Garj\u00f3n","year":"2020","unstructured":"Garj\u00f3n J, Saiz LC, Azparren A, et al. First-line combination therapy versus first-line monotherapy for primary hypertension. Cochrane Database Syst Rev. 2020;2(2):CD010316. https:\/\/doi.org\/10.1002\/14651858.CD010316.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1324_CR24","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1097\/HJH.0000000000002096","volume":"37","author":"A Salam","year":"2019","unstructured":"Salam A, Kanukula R, Atkins E, et al. Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37(9):1768\u201374. https:\/\/doi.org\/10.1097\/HJH.0000000000002096.","journal-title":"J Hypertens"},{"key":"1324_CR25","doi-asserted-by":"publisher","unstructured":"MacDonald TM, Williams B, Webb DJ, et al. Combination therapy is Superior to Sequential Monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial. J Am Heart Assoc. 2017;6(11). https:\/\/doi.org\/10.1161\/JAHA.117.006986.","DOI":"10.1161\/JAHA.117.006986"},{"key":"1324_CR26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher A, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887\u201398. https:\/\/doi.org\/10.1056\/NEJMoa0801369.","journal-title":"N Engl J Med"},{"issue":"20","key":"1324_CR27","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1093\/eurheartj\/ehr177","volume":"32","author":"PS Sever","year":"2011","unstructured":"Sever PS, Messerli FH. Hypertension management 2011: optimal combination therapy. Eur Heart J. 2011;32(20):2499\u2013506. https:\/\/doi.org\/10.1093\/eurheartj\/ehr177.","journal-title":"Eur Heart J"},{"issue":"6","key":"1324_CR28","first-page":"341","volume":"101","author":"DK Smith","year":"2020","unstructured":"Smith DK, Lennon RP, Carlsgaard PB. Managing hypertension using combination therapy. Am Fam Physician. 2020;101(6):341\u20139.","journal-title":"Am Fam Physician"},{"issue":"2","key":"1324_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/jch.13475","volume":"21","author":"M Shani","year":"2019","unstructured":"Shani M, Lustman A, Vinker S. Adherence to oral antihypertensive medications, are all medications equal? J Clin Hypertens (Greenwich). 2019;21(2):243\u20138. https:\/\/doi.org\/10.1111\/jch.13475.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"1324_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jch.14616","volume":"25","author":"Q-H Guo","year":"2023","unstructured":"Guo Q-H, Zhu Z-M, Feng Y-Q, et al. Blood pressure lowering effects of \u03b2-blockers as add-on or combination therapy: a meta-analysis of randomized controlled trials. J Clin Hypertens (Greenwich). 2023;25(3):227\u201337. https:\/\/doi.org\/10.1111\/jch.14616.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"5","key":"1324_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320. https:\/\/doi.org\/10.1001\/jama.2013.284427.","journal-title":"JAMA"},{"issue":"8","key":"1324_CR32","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1097\/HJH.0000000000002089","volume":"37","author":"A Salam","year":"2019","unstructured":"Salam A, Atkins ER, Hsu B, et al. Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2019;37(8):1567\u201373. https:\/\/doi.org\/10.1097\/HJH.0000000000002089.","journal-title":"J Hypertens"},{"issue":"2","key":"1324_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tcm.2019.03.002","volume":"30","author":"M Volpe","year":"2020","unstructured":"Volpe M, Gallo G, Tocci G. New approach to blood pressure control: triple combination pill. Trends Cardiovasc Med. 2020;30(2):72\u20137. https:\/\/doi.org\/10.1016\/j.tcm.2019.03.002.","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"1324_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jama.2018.10359","volume":"320","author":"R Webster","year":"2018","unstructured":"Webster R, Salam A, de Silva HA, et al. Fixed low-dose Triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a Randomized Clinical Trial. JAMA. 2018;320(6):566\u201379. https:\/\/doi.org\/10.1001\/jama.2018.10359.","journal-title":"JAMA"},{"issue":"5","key":"1324_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.anai.2021.07.028","volume":"127","author":"JC Garcia-Saucedo","year":"2021","unstructured":"Garcia-Saucedo JC, Trejo-Guitierrez JF, Volcheck GW, et al. Incidence and risk factors of angiotensin-converting enzyme inhibitor\u2013induced angioedema: a large case-control study. Ann Allergy Asthma Immunol. 2021;127(5):591\u20132. https:\/\/doi.org\/10.1016\/j.anai.2021.07.028.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"1324_CR36","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/jch.13097","volume":"19","author":"T Brown","year":"2017","unstructured":"Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor\u2013induced angioedema: a review of the literature. J Clin Hypertens (Greenwich). 2017;19(12):1377\u201382. https:\/\/doi.org\/10.1111\/jch.13097.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"20","key":"1324_CR37","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"S Toh","year":"2012","unstructured":"Toh S, Reichman M, Houstoun M, et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med. 2012;172(20):1582\u20139. https:\/\/doi.org\/10.1001\/2013.jamainternmed.34.","journal-title":"Arch Intern Med"},{"issue":"11","key":"1324_CR38","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamainternmed.2019.3007","volume":"179","author":"TS Anderson","year":"2019","unstructured":"Anderson TS, Jing B, Auerbach A, et al. Clinical outcomes after intensifying antihypertensive medication regimens among older adults at hospital discharge. JAMA Intern Med. 2019;179(11):1528\u201336. https:\/\/doi.org\/10.1001\/jamainternmed.2019.3007.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1324_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/MLR.0000000000001064","volume":"57","author":"T-Y Chen","year":"2019","unstructured":"Chen T-Y, Kao C-W, Cheng S-M, et al. Effect of Home Medication Titration on blood pressure control in patients with hypertension: a meta-analysis of randomized controlled trials. Med Care. 2019;57(3):230\u20136. https:\/\/doi.org\/10.1097\/MLR.0000000000001064.","journal-title":"Med Care"},{"issue":"5","key":"1324_CR40","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/HYPERTENSIONAHA.119.12676","volume":"74","author":"M Azizi","year":"2019","unstructured":"Azizi M, Rossignol P, Hulot J-S. Emerging drug classes and their potential use in hypertension. Hypertension. 2019;74(5):1075\u201383. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.12676.","journal-title":"Hypertension"},{"issue":"30","key":"1324_CR41","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehv142","volume":"36","author":"C Bavishi","year":"2015","unstructured":"Bavishi C, Messerli FH, Kadosh B, et al. Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. Eur Heart J. 2015;36(30):1967\u201373. https:\/\/doi.org\/10.1093\/eurheartj\/ehv142.","journal-title":"Eur Heart J"},{"key":"1324_CR42","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1038\/nutd.2014.40","volume":"4","author":"B Haas","year":"2014","unstructured":"Haas B, Eckstein N, Pfeifer V, et al. Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin. Nutr Diabetes. 2014;4:e143. https:\/\/doi.org\/10.1038\/nutd.2014.40.","journal-title":"Nutr Diabetes"},{"issue":"4","key":"1324_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2337\/dc18-2207","volume":"42","author":"PI Georgianos","year":"2019","unstructured":"Georgianos PI, Agarwal R. Ambulatory blood pressure reduction with SGLT-2 inhibitors: dose-response Meta-analysis and comparative evaluation with low-dose hydrochlorothiazide. Diabetes Care. 2019;42(4):693\u2013700. https:\/\/doi.org\/10.2337\/dc18-2207.","journal-title":"Diabetes Care"},{"issue":"11","key":"1324_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11906-020-01109-2","volume":"22","author":"J An","year":"2020","unstructured":"An J, Derington CG, Luong T, et al. Fixed-dose combination medications for treating hypertension: a review of effectiveness, Safety, and challenges. Curr Hypertens Rep. 2020;22(11):95. https:\/\/doi.org\/10.1007\/s11906-020-01109-2.","journal-title":"Curr Hypertens Rep"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01324-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-025-01324-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-025-01324-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:02:52Z","timestamp":1770476572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-025-01324-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1007\/s11906-025-01324-9","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"2 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6"}}